Clinical Trial Update: The Efficacy and Safety of Aracmyn in Patients With Systemic Latrodectism [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of Aracmyn in systemic latrodectism has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latrodectism

Drugs mentioned

• Aracmyn

Snippet

Sponsor: Instituto Bioclon S.A. de C.V. | Conditions: Arachnidism, Latrodectism | Phase 2 | Status: COMPLETED